Name: UMIN ID:
Unique ID issued by UMIN | UMIN000016138 |
---|---|
Receipt number | R000018738 |
Scientific Title | A Randomized, Open Label, Phase II Trial of Bevacizumab Plus Weekly Paclitaxel Followed by Bevacizumab Monotherapy Maintenance Versus Weekly Paclitaxel Followed by Observation in Patients With Relapsed Ovarian Sex-cord Stromal Tumours |
Date of disclosure of the study information | 2015/01/07 |
Last modified on | 2019/02/25 13:00:41 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/01/06 20:34:30 | ||
2 | Update | 2015/08/10 12:09:29 | Name of person sending information Name of person sending information Email1 Institutions |
|
3 | Update | 2017/03/30 14:54:53 | Recruitment status |
|
4 | Update | 2017/07/28 10:26:04 | Randomization unit |
|
5 | Update | 2017/07/28 10:34:23 | Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL Name of primary person or sponsor Organization Organization1 Address1 Tel1 Email1 |
|
6 | Update | 2018/01/09 16:03:18 | Institutions |
|
7 | Update | 2018/07/11 12:58:58 | Name of person sending information Name of person sending information Institutions |
|
8 | Update | 2019/02/25 13:00:41 | Recruitment status Last follow-up date |